HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Victoria Catalán Selected Research

Therapeutics

2/2023Increased Aquaporin-7 Expression Is Associated with Changes in Rat Brown Adipose Tissue Whitening in Obesity: Impact of Cold Exposure and Bariatric Surgery.
6/2021Caloric Restriction Prevents Metabolic Dysfunction and the Changes in Hypothalamic Neuropeptides Associated with Obesity Independently of Dietary Fat Content in Rats.
1/2018NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development.
1/2017The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes.
1/2016Increased Obesity-Associated Circulating Levels of the Extracellular Matrix Proteins Osteopontin, Chitinase-3 Like-1 and Tenascin C Are Associated with Colon Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Victoria Catalán Research Topics

Disease

78Obesity
02/2024 - 01/2004
40Inflammation (Inflammations)
02/2024 - 03/2006
31Weight Loss (Weight Reduction)
02/2024 - 03/2006
26Type 2 Diabetes Mellitus (MODY)
02/2024 - 11/2007
26Insulin Resistance
11/2023 - 09/2006
14Morbid Obesity
07/2023 - 03/2006
10Non-alcoholic Fatty Liver Disease
10/2023 - 07/2012
9Body Weight (Weight, Body)
11/2023 - 04/2010
6Fibrosis (Cirrhosis)
10/2023 - 01/2014
6Colonic Neoplasms (Colon Cancer)
02/2023 - 07/2011
6Hypoxia (Hypoxemia)
08/2021 - 07/2011
5Fatty Liver
10/2023 - 01/2017
5Neoplasms (Cancer)
01/2018 - 10/2013
4Metabolic Diseases (Metabolic Disease)
01/2022 - 03/2013
4Glucose Intolerance
01/2022 - 10/2014
4Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2018 - 01/2007
3Hypertension (High Blood Pressure)
03/2010 - 08/2006
2Liver Cirrhosis (Hepatic Cirrhosis)
07/2023 - 01/2019
2Colorectal Neoplasms (Colorectal Cancer)
02/2023 - 01/2018
2Dyslipidemias (Dyslipidemia)
11/2021 - 10/2016
2Necrosis
10/2018 - 07/2011
2Abdominal Obesity
01/2017 - 02/2009
2Hyperglycemia
05/2011 - 04/2011
2Overweight
01/2010 - 09/2007
1Mitochondrial Diseases (Mitochondrial Disease)
10/2023
1Weight Gain
01/2022
1Carcinogenesis
08/2021
1Hyperinsulinism (Hyperinsulinemia)
06/2021

Drug/Important Bio-Agent (IBA)

18LeptinIBA
12/2022 - 08/2006
17Messenger RNA (mRNA)IBA
02/2024 - 03/2006
13Glucose (Dextrose)FDA LinkGeneric
11/2023 - 09/2006
12AdipokinesIBA
04/2020 - 01/2007
12Proteins (Proteins, Gene)FDA Link
01/2020 - 06/2009
11AdiponectinIBA
11/2023 - 10/2008
9Glycerol (Glycerine)FDA LinkGeneric
02/2023 - 07/2006
8Insulin (Novolin)FDA Link
11/2023 - 10/2008
8CytokinesIBA
01/2022 - 11/2007
8OsteopontinIBA
01/2017 - 09/2007
7GhrelinIBA
11/2023 - 03/2010
7LipidsIBA
01/2022 - 10/2008
6Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2014
5salicylhydroxamic acid (SHAM)IBA
11/2023 - 02/2012
5HDL CholesterolIBA
01/2023 - 01/2010
5Interleukin-8 (Interleukin 8)IBA
01/2021 - 01/2017
5Interleukin-6 (Interleukin 6)IBA
01/2021 - 07/2011
5Triglycerides (Triacylglycerol)IBA
01/2018 - 07/2006
4Interleukin-18 (Interleukin 18)IBA
02/2024 - 01/2018
4InflammasomesIBA
02/2024 - 01/2018
4Conditioned Culture MediaIBA
02/2023 - 01/2021
4Protein Isoforms (Isoforms)IBA
01/2022 - 03/2010
4Angiopoietin-Like Protein 8IBA
11/2021 - 10/2014
4AquaglyceroporinsIBA
09/2015 - 04/2011
3guanylinIBA
10/2023 - 01/2022
3Hormones (Hormone)IBA
10/2023 - 03/2010
3Extracellular Matrix ProteinsIBA
02/2023 - 01/2016
3Chemotactic FactorsIBA
01/2022 - 01/2011
3InterleukinsIBA
08/2021 - 12/2016
3LipopolysaccharidesIBA
08/2021 - 10/2018
3fibroblast growth factor 21IBA
01/2021 - 01/2017
3des-n-octanoyl ghrelinIBA
01/2019 - 03/2010
3Fatty Acids (Saturated Fatty Acids)IBA
01/2018 - 06/2009
3Serum Amyloid A Protein (Serum Amyloid A)IBA
01/2017 - 03/2006
3Lipocalin-2IBA
05/2015 - 07/2011
2Small Interfering RNA (siRNA)IBA
02/2024 - 01/2021
2Glucagon-Like Peptide 1 (GLP 1)IBA
11/2023 - 04/2019
2preproguanylinIBA
10/2023 - 01/2022
2prouroguanylinIBA
10/2023 - 01/2022
2NetrinsIBA
02/2023 - 10/2022
2neogeninIBA
02/2023 - 10/2022
2Netrin-1IBA
02/2023 - 10/2022
2Peptides (Polypeptides)IBA
01/2023 - 04/2014
2C-Reactive ProteinIBA
01/2023 - 01/2017
2Dietary Fats (Dietary Fat)IBA
01/2022 - 06/2021
2Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
10/2017 - 01/2017
2TenascinIBA
01/2016 - 10/2012
2IronIBA
04/2014 - 09/2013
2MicroRNAs (MicroRNA)IBA
05/2013 - 09/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2013 - 11/2007
2Complement System Proteins (Complement)IBA
09/2012 - 01/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2011 - 08/2010
1EndotoxinsIBA
02/2024
1zonulinIBA
02/2024
1uroguanylinIBA
10/2023
1Ghrelin ReceptorsIBA
07/2023
1Uric Acid (Urate)IBA
01/2023
1Interleukin-1 (Interleukin 1)IBA
01/2022
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2022
1Cathepsin GIBA
01/2022
1microfibrillar proteinIBA
08/2021
1NeuropeptidesIBA
06/2021
1Interleukin-33IBA
01/2021
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2020
1Exenatide (Byetta)FDA Link
04/2019

Therapy/Procedure

19Bariatric Surgery
11/2023 - 04/2014
15Gastric Bypass (Roux-en-Y Gastric Bypass)
07/2023 - 03/2006
14Gastrectomy
11/2023 - 09/2011
7Caloric Restriction
11/2023 - 09/2012
5Therapeutics
02/2023 - 01/2016
2Operative Surgical Procedures
09/2012 - 02/2012
1Glycemic Control
11/2023